NeoGenomics, Inc.
NEO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $188 | $181 | $168 | $172 |
| % Growth | 3.6% | 7.9% | -2.3% | – |
| Cost of Goods Sold | $107 | $104 | $95 | $95 |
| Gross Profit | $80 | $77 | $73 | $77 |
| % Margin | 42.8% | 42.6% | 43.6% | 44.9% |
| R&D Expenses | $9 | $9 | $10 | $8 |
| G&A Expenses | $70 | $72 | $68 | $64 |
| SG&A Expenses | $92 | $96 | $91 | $86 |
| Sales & Mktg Exp. | $22 | $24 | $23 | $22 |
| Other Operating Expenses | $7 | $20 | $0 | $2 |
| Operating Expenses | $107 | $125 | $101 | $96 |
| Operating Income | -$27 | -$48 | -$28 | -$18 |
| % Margin | -14.4% | -26.3% | -16.6% | -10.7% |
| Other Income/Exp. Net | $1 | $2 | $2 | $2 |
| Pre-Tax Income | -$26 | -$46 | -$26 | -$16 |
| Tax Expense | $1 | -$1 | $0 | -$1 |
| Net Income | -$27 | -$45 | -$26 | -$15 |
| % Margin | -14.4% | -24.9% | -15.4% | -8.9% |
| EPS | -1.05 | -1.75 | -1 | -0.6 |
| % Growth | 40% | -75% | -66.7% | – |
| EPS Diluted | -1.05 | -1.75 | -1 | -0.6 |
| Weighted Avg Shares Out | 26 | 26 | 25 | 25 |
| Weighted Avg Shares Out Dil | 26 | 26 | 25 | 25 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $2 | $4 | $4 |
| Interest Expense | $0 | $1 | $2 | $2 |
| Depreciation & Amortization | $16 | $17 | $18 | $18 |
| EBITDA | -$10 | -$28 | -$6 | $4 |
| % Margin | -5.3% | -15.2% | -3.8% | 2.1% |